RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
7.04
+0.47 (7.15%)
Aug 11, 2026, 4:00 PM EDT - Market closed
RxSight Market Cap
RxSight has a market cap or net worth of $292.82 million as of August 11, 2026. Its market cap has decreased by -0.47% in one year.
Market Cap
292.82M
Enterprise Value
94.60M
1-Year Change
-0.47%
Ranking
Category
Stock Price
$7.04
ChartMarket Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $292.82M, a decrease of -30.99%. That is a compound annual growth rate of -7.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 292.82M | -31.65% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 908 Devices | 364.32M |
| CapsoVision | 354.74M |
| Electromed | 349.34M |
| TriSalus Life Sciences | 345.43M |
| Perspective Therapeutics | 342.14M |
| Standard BioTools | 313.17M |
| Treace Medical Concepts | 308.80M |
| Profound Medical | 268.54M |